|WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research|
DN Slenter, M Kutmon, K Hanspers, A Riutta, J Windsor, N Nunes, ...
Nucleic acids research 46 (D1), D661-D667, 2018
|Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification|
MA La Merrill, LN Vandenberg, MT Smith, W Goodson, P Browne, ...
Nature Reviews Endocrinology, 2019
|Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen|
MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ...
Nature communications 10 (1), 1-17, 2019
|Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma|
L Rieswijk, SMH Claessen, O Bekers, M van Herwijnen, DHJ Theunissen, ...
Toxicology 350, 31-39, 2016
|A data fusion pipeline for generating and enriching adverse outcome pathway descriptions|
P Nymark, L Rieswijk, F Ehrhart, N Jeliazkova, G Tsiliki, H Sarimveis, ...
Toxicological Sciences 162 (1), 264-275, 2018
|Proposed key characteristics of female reproductive toxicants as an approach for organizing and evaluating mechanistic data in hazard assessment|
U Luderer, B Eskenazi, R Hauser, KS Korach, CM McHale, F Moran, ...
Environmental health perspectives 127 (7), 075001, 2019
|The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure ThemKey Characteristics of Carcinogens: Assays and …|
MT Smith, KZ Guyton, N Kleinstreuer, A Borrel, A Cardenas, WA Chiu, ...
Cancer Epidemiology, Biomarkers & Prevention 29 (10), 1887-1903, 2020
|Key characteristics approach to carcinogenic hazard identification|
KZ Guyton, L Rieswijk, A Wang, WA Chiu, MT Smith
Chemical research in toxicology 31 (12), 1290-1292, 2018
|Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes|
L Rieswijk, KJJ Brauers, MLJ Coonen, SGJ Van Breda, DGJ Jennen, ...
Mutagenesis 30 (6), 771-784, 2015
|A state-of-the-science review of arsenic’s effects on glucose homeostasis in experimental models|
F Castriota, L Rieswijk, S Dahlberg, MA La Merrill, C Steinmaus, MT Smith, ...
Environmental health perspectives 128 (1), 016001, 2020
|Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women|
JYY Wong, H Zhang, CA Hsiung, K Shiraishi, K Yu, K Matsuo, MP Wong, ...
Genomics 112 (2), 1223-1232, 2020
|Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating …|
L Rieswijk, D Lizarraga, KJJ Brauers, JCS Kleinjans, JHM van Delft
Mutagenesis 29 (1), 17-26, 2014
|Formaldehyde and brain disorders: a meta-analysis and bioinformatics approach|
I Rana, L Rieswijk, C Steinmaus, L Zhang
Neurotoxicity research 39 (3), 924-948, 2021
|Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and …|
RV Phillips, L Rieswijk, AE Hubbard, R Vermeulen, J Zhang, W Hu, L Li, ...
Epigenetics 14 (11), 1112-1124, 2019
|Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and …|
L Rieswijk, KJJ Brauers, MLJ Coonen, DGJ Jennen, SGJ van Breda, ...
Mutagenesis 31 (5), 603-615, 2016
|eNanoMapper–A database and ontology framework for design and safety assessment of nanomaterials|
G Kilic, B Fadeel, L Farcal, H Sarimveis, P Doganis, G Drakakis, G Tsiliki, ...
Toxicology Letters, S118-S119, 2016
|Answering Scientific Questions with linked European Nanosafety Data.|
EL Willighagen, M Rautenberg, D Gebele, L Rieswijk, F Ehrhart, J Chang, ...
|Persistent transcriptional responses show the involvement of feed-forward control in a repeated dose toxicity study|
TM Souza, L Rieswijk, T van den Beucken, J Kleinjans, D Jennen
Toxicology 375, 58-63, 2017
|eNanoMapper updates and its collaborations with the community|
E Willighagen, F Ehrhart, L Rieswijk, N Jeliazkova, CTA Evelo, L Farcal, ...
NanoSafety Cluster Newsletter 6, 14-17, 2015
|An approach to the proposal of drug combination for cancer therapy using a pathway data connectivity approach|
R Miller, S Muraru, AB Malpartida, J Low, MP de Almeida, B van Engelen, ...